Company Information

DR LALCHANDANI LABS LTD.

NSE : NABSE : 541299ISIN CODE : INE871Z01013Industry : Hospital & Healthcare ServicesHouse : Private
BSE20.850 (0 %)
PREV CLOSE ( ) 20.85
OPEN PRICE ( ) 21.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 12000
TODAY'S LOW / HIGH ( )20.81 21.00
52 WK LOW / HIGH ( ) 15.6835
NSE
This Company is not listed in NSE
ChairmanArjan Lalchandani
Managing DirectorArjan Lalchandani
Executive DirectorAnchal Gupta
Non Executive DirectorSwati Chandra
Non Executive Independent DirectorRajiv Handa
Prakash Jhuraney
Whole Time DirectorMohit Lalchandani
Incorporation Year : 15-09 2011

Registered Office :

Address : M-20, Basement,Greater Kailash,Part-1 New Delhi,
Delhi-110048 .

Phone : 011 49057058/59

Industry : Hospital & Healthcare Services

Listing : BSE

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.